The Scholarships360 Research Team reviews all scholarships individually and strives to exclude any scholarship where any of the below applies:
If you believe a scholarship has been published in error, please reach out to [email protected] and we’ll take a look!
* There are certain exceptions to this, for example if the sponsoring organization is a major corporation or nonprofit with its own scholarship application system.
** Lead generation scholarships will require students to sign up for an app or website and require minimal (if any) application requirements.
***Idea harvesting scholarships will require students to submit blog posts or other materials that companies may use for marketing purposes.
Higher education has never been more confusing or expensive. Our goal is to help you navigate the very big decisions related to higher ed with objective information and expert advice. Each piece of content on the site is original, based on extensive research, and reviewed by multiple editors, including a subject matter expert. This ensures that all of our content is up-to-date, useful, accurate, and thorough.
Our reviews and recommendations are based on extensive research, testing, and feedback. We may receive commission from links on our website, but that doesn’t affect our editors’ opinions. Our marketing partners don’t review, approve or endorse our editorial content. It’s accurate to the best of our knowledge when posted. You can find a complete list of our partners here.
This scholarship has been verified by the scholarship providing organization.
Offered by BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. has established a scholarship program to assist high school seniors, graduates, current postsecondary undergraduates, or graduate level students who have been diagnosed by a physician with having achondroplasia, Batten disease, hemophilia A, mucopolysaccharidosis (MPS) or phenylketonuria (PKU), regardless of treatment status. This program is administered by Scholarship America, the nation’s largest designer and manager of scholarships and other education support programs for corporations, foundations, associations and individuals. Eligibility for individual programs is determined at the sole discretion of the sponsor, and eligible applications are reviewed by Scholarship America’s evaluation team.
Applicants are not required to have undergone treatment with a BioMarin therapy. Treatment status with any manufacturer products should not be disclosed and will not be considered in evaluating applications. Applicants must be enrolled or plan to be enrolled as a full- or part-time (minimum 6 credits per term) undergraduate or graduate student at an accredited two-year or four-year college, university or vocational-technical school for the entire 2024-2025 academic year. Applicants must be U.S. or ex-U.S. residents enrolled in U.S.-based schools, including U.S. territories. Schools may be non-profit or for-profit. Applicants must have a minimum grade point average of 3.0 (or equivalent) on a 4.0 scale.
BioMarin, established in 1997, is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases.
This scholarship is open to students meeting the below eligibility criteria.
High School Seniors, College & Graduate Students
U.S. Citizens, Canadian Citizens, Permanent Residents, Other
3.0
Applicants must have been diagnosed with mucopolysaccharidoses (MPS), phenylketonuria (PKU), Batten disease, or achondroplasia.
In addition to the below application materials, applicants must submit (1) proof of diagnosis and (2) a doctor’s statement with their diagnosis.
Academic transcript
Letter of recommendation
Create your Scholarships360 account to confirm your eligibility for the RARE Scholars. 0% Spam, 100% Free.
Apply to these exclusive scholarships
See all opportunitiesWhile you wait for this scholarship to reopen, try applying to some additional opportunities
Get StartedBy the way...Scholarships360 is 100% free!
Join For Free